- Home
- ADTX vs GLMD Comparison
ADTX vs GLMD Comparison
Compare ADTX & GLMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADTX
- GLMD
- Stock Information
- Founded
- ADTX 2017
- GLMD 2000
- Country
- ADTX United States
- GLMD Israel
- Employees
- ADTX N/A
- GLMD N/A
- Industry
- ADTX Biotechnology: Pharmaceutical Preparations
- GLMD Biotechnology: Pharmaceutical Preparations
- Sector
- ADTX Health Care
- GLMD Health Care
- Exchange
- ADTX Nasdaq
- GLMD Nasdaq
- Market Cap
- ADTX 3.1M
- GLMD 3.0M
- IPO Year
- ADTX 2020
- GLMD 2014
- Fundamental
- Price
- ADTX $1.39
- GLMD $1.81
- Analyst Decision
- ADTX
- GLMD Hold
- Analyst Count
- ADTX 0
- GLMD 1
- Target Price
- ADTX N/A
- GLMD N/A
- AVG Volume (30 Days)
- ADTX 1.2M
- GLMD 364.3K
- Earning Date
- ADTX 08-18-2025
- GLMD 05-22-2025
- Dividend Yield
- ADTX N/A
- GLMD N/A
- EPS Growth
- ADTX N/A
- GLMD N/A
- EPS
- ADTX N/A
- GLMD N/A
- Revenue
- ADTX $55,323.00
- GLMD N/A
- Revenue This Year
- ADTX $15,768.94
- GLMD N/A
- Revenue Next Year
- ADTX N/A
- GLMD N/A
- P/E Ratio
- ADTX N/A
- GLMD N/A
- Revenue Growth
- ADTX N/A
- GLMD N/A
- 52 Week Low
- ADTX $1.28
- GLMD $1.15
- 52 Week High
- ADTX $27,200.00
- GLMD $23.80
- Technical
- Relative Strength Index (RSI)
- ADTX 44.87
- GLMD 61.13
- Support Level
- ADTX $1.28
- GLMD $1.63
- Resistance Level
- ADTX $2.19
- GLMD $1.94
- Average True Range (ATR)
- ADTX 0.15
- GLMD 0.12
- MACD
- ADTX 0.08
- GLMD 0.01
- Stochastic Oscillator
- ADTX 30.77
- GLMD 69.77
About ADTX Aditxt Inc.
Aditxt Inc is a life sciences company that develops, builds, and grows innovations with a focus on monitoring and modulating the immune system. It develops products designed to induce tolerance to transplanted organs. Its portfolio consists of two programs Adimune and AditxtScore. It firm's immunosuppressive (anti-rejection) drugs have made possible life-saving organ transplantation procedures and blocking of unwanted immune responses in autoimmune diseases. It is also developing a technology called Apoptotic DNA Immunotherapy (ADi) ADI-100, which utilizes a novel approach that mimics, the way bodies naturally induce tolerance to tissues.
About GLMD Galmed Pharmaceuticals Ltd.
Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development of Aramchol. exclusively on developing Aramchol for the treatment of liver disease and were previously developing Aramchol for primary sclerosing cholangitis, PSC, and exploring the feasibility of developing Aramchol for other fibro-inflammatory indications outside of NASH and fibrosis. The company is currently seeking to advance the development of Aramchol for oncological indications outside of NASH and fibrosis.